Open access peer-reviewed chapter

Nuclear Translocation of YB-1 Protein Induced by Ultraviolet Light and the Investigational Gallium Drug GaQ3 in Melanoma Cells

By Seied Mojtaba Valiahdi, Michael A. Jakupec, Sara Daraei, Franz Wohlrab and Bernhard K. Keppler

Submitted: November 24th 2010Reviewed: May 5th 2011Published: November 14th 2011

DOI: 10.5772/23185

Downloaded: 1392

© 2011 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution 3.0 License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to cite and reference

Link to this chapter Copy to clipboard

Cite this chapter Copy to clipboard

Seied Mojtaba Valiahdi, Michael A. Jakupec, Sara Daraei, Franz Wohlrab and Bernhard K. Keppler (November 14th 2011). Nuclear Translocation of YB-1 Protein Induced by Ultraviolet Light and the Investigational Gallium Drug GaQ3 in Melanoma Cells, Breakthroughs in Melanoma Research, Yohei Tanaka, IntechOpen, DOI: 10.5772/23185. Available from:

chapter statistics

1392total chapter downloads

More statistics for editors and authors

Login to your personal dashboard for more detailed statistics on your publications.

Access personal reporting

Related Content

This Book

Next chapter

Novel Approach to the Characterization of Melanoma Associated-Peptide-Specific CTL Lines from Melanoma Patients

By Yasuto Akiyama, Masaru Komiyama, Akira Iizuka, Akifumi Yamamoto, Naoya Yamazaki and Yoshio Kiyohara

Related Book

First chapter

Photosensitizers Imprinting Intracellular Signaling Pathways in Dermato-Oncology Therapy

By Carolina Constantin and Monica Neagu

We are IntechOpen, the world's leading publisher of Open Access books. Built by scientists, for scientists. Our readership spans scientists, professors, researchers, librarians, and students, as well as business professionals. We share our knowledge and peer-reveiwed research papers with libraries, scientific and engineering societies, and also work with corporate R&D departments and government entities.

More About Us